Details for Patent: 9,981,013
✉ Email this page to a colleague
Summary for Patent: 9,981,013
Title: | Use of AVE0010 for the treatment of diabetes mellitus type 2 |
Abstract: | The present invention refers to the use of Lixisenatide or/and a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of diabetes mellitus type 2, for inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients. |
Inventor(s): | Boka; Gabor (Paris, FR), Miossec; Patrick (Paris, FR), Silvestre; Louise (Paris, FR) |
Assignee: | SANOFI-AVENTIS DEUTSCHLAND GMBH (Frankfurt am Main, DE) |
Application Number: | 15/237,285 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,981,013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,981,013
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010360116 | ⤷ Try a Trial | |||
Brazil | 112013004756 | ⤷ Try a Trial | |||
Canada | 2809321 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |